What is the clinical evidence from this study?

Study design: Observational. Population: Mitral valve disease (n=53). Intervention: Totally thoracoscopic mitral valve procedure. Primary outcome: Short-term major adverse events (intraoperative conversion to sternotomy, re-exploration for bleeding, valve-related reoperation, and death).

December 1, 2018Journal of Cardiothoracic SurgeryOpen Access

Feasibility, safety, and short-term outcome of totally thoracoscopic mitral valve procedure

View Full Paper

Ask AI

Bookmark

Key result

The totally thoracoscopic mitral valve procedure was technically feasible and safe, with a 3.8% rate of conversion to sternotomy and one in-hospital death among 53 patients.

Why the study?

The authors investigated the feasibility, safety, and effectiveness of the minimally invasive totally thoracoscopic procedure for mitral valve disease when performed by an experienced operator.

Population

53 consecutive patients with MV disease

Comparison

Totally thoracoscopic MV procedure

Design

Retrospective observational study

Authors

QJQin JiangUniversity of Electronic Science and Technology of China TYTao YuQingdao University KHKeli HuangZhejiang A & F University

Discussion

Member takes

Implication

Does not support practice change; leaves open need for randomized comparisons to conventional approaches.

Study Design

Type

Observational (n=53)

Multicenter

Structured PICO

Population

53 patients (mean age 49 years, 74.5% female) with mitral valve disease undergoing totally thoracoscopic mitral valve procedures to assess short-term safety and feasibility.

Intervention

Totally thoracoscopic mitral valve procedure (replacement or repair) on femoral artery-vein bypass through three 2-4 cm incisions and one penetrating point on the right chest wall under transoesophageal echocardiography surveillance.

Outcome

Feasibility, safety, and short-term outcomes including cardiopulmonary bypass time, aortic cross clamp time, chest tube drainage, ventilation time, intensive care unit stay length, and mortality.safety

Totally thoracoscopic mitral valve procedures are technically feasible and safe when performed by experienced surgeons.

Limitations

Retrospective, single-center design
Small sample size
Procedures performed by a single experienced surgeon, limiting generalizability
Lack of stereoscopic vision and steep learning curve

Cite This Study

Jiang et al. (2018) conducted an observational in Mitral valve disease (n=53). Totally thoracoscopic mitral valve procedure was evaluated on Short-term major adverse events (intraoperative conversion to sternotomy, re-exploration for bleeding, valve-related reoperation, and death). The totally thoracoscopic mitral valve procedure was technically feasible and safe, with a 3.8% rate of conversion to sternotomy and one in-hospital death among 53 patients.

synapsesocial.com/papers/6a9546358ce716a7e9fa6c6e https://doi.org/10.1186/s13019-018-0819-1

Topics

Valvular heart disease

View Full Paper

Ask AI

Bookmark

Feasibility, safety, and short-term outcome of totally thoracoscopic mitral valve procedure

Discussion

Member takes

Implication

Study Design

Structured PICO

Limitations

Cite This Study

Topics

Feasibility, safety, and short-term outcome of totally thoracoscopic mitral valve procedure

Discussion

Member takes

Implication

Study Design

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider